Related Experiment Video
Updated: Apr 21, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Comparison of ondansetron and meperidine for treatment of postoperative shivering: a randomized controlled clinical
Alireza Mahoori1, Heydar Noroozinia1, Ebrahim Hasani1
1Department of Anesthesiology, Imam Khomeini Training Hospital, Urmia University of Medical Sciences, Urmia, IR Iran.
Background:
The involved neurotransmitter pathways in the postoperative shivering (POS) are poorly understood. Recently, 5-hydroxytryptamine 3 (5-HT3) receptor antagonists have been reported to prevent POS. We investigated the effect of ondansetron, a 5-HT3 antagonist that is used to treat postoperative nausea and vomiting, on shivering.
Objectives:
This study aimed to compare the efficacy of ondansetron and meperidine in the treatment of shivering after general anesthesia.
Patients And Methods:
In this double-blinded randomized clinical trial, 83 patients (age range, 18-60 years) who had shivering after general anesthesia were randomly allocated to any of these three groups: Group A, (number = 27) received 4 mg of intravenous ondansetron, Group B, (number = 27) received 8 mg of intravenous ondansetron, and Group C, (number = 29) received 0.4 mg/kg of intravenous meperidine at recovery room. The surface temperatures and the incidence as well as intensity of shivering were recorded.
Results:
Shivering was controlled in 16 patients (59%) in Group A, 22 (81%) in Group B, and 25 (86%) in Group C (P = 0.01). Within each group, there were no significant differences among the surface temperature in recovery room. Patients in groups A and B had significantly lower incidence of nausea and vomiting than group C (P = 0.01).
Conclusions:
Ondansetron and meperidine have similar effects on shivering. We concluded that 8 mg of intravenous ondansetron can control shivering and this is the dose of choice, especially in patients with POS with nausea and vomiting.
Insights
Ondansetron effectively controls postoperative shivering, with 8 mg being the recommended dose, especially for patients experiencing nausea and vomiting. This study compared ondansetron to meperidine for treating shivering.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Postoperative shivering (POS) involves poorly understood neurotransmitter pathways.
- 5-hydroxytryptamine 3 (5-HT3) receptor antagonists show promise in preventing POS.
- Ondansetron, a 5-HT3 antagonist, is commonly used for postoperative nausea and vomiting.
Purpose of the Study:
- To compare the efficacy of ondansetron and meperidine in treating shivering after general anesthesia.
- To determine the optimal ondansetron dosage for managing postoperative shivering.
Main Methods:
- A double-blinded randomized clinical trial involving 83 patients (18-60 years) experiencing shivering post-general anesthesia.
- Patients were allocated to receive 4 mg ondansetron (n=27), 8 mg ondansetron (n=27), or 0.4 mg/kg meperidine (n=29) intravenously.
- Surface temperatures, and the incidence and intensity of shivering were recorded.
Main Results:
- Shivering control rates were 59% for 4 mg ondansetron, 81% for 8 mg ondansetron, and 86% for meperidine (P=0.01).
- No significant differences in surface temperature were observed within groups.
- Groups receiving ondansetron reported significantly lower incidence of nausea and vomiting compared to the meperidine group (P=0.01).
Conclusions:
- Ondansetron and meperidine demonstrate comparable efficacy in managing postoperative shivering.
- 8 mg of intravenous ondansetron is identified as the preferred dose for controlling shivering.
- Ondansetron is particularly suitable for patients with postoperative shivering accompanied by nausea and vomiting.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Methods of reducing fever
Pharmacological Methods of Reducing Fever: